领航医药生物科技(00399.HK)拟设合营拓中国一次性体检用消化内窥镜市场

阿斯达克财经08-27

领航医药生物科技(00399.HK) 公布，就可能成立合营企业与策略伙伴湖南省华芯医疗器械订立谅解备忘录，双方拟合作开拓及发展中国一次性体检用消化内窥镜市场。双方亦同意讨论可能合营企业于中国的可行性及发展，并致力于10月31日或之前订立具法律约束力的合营企业协议。华芯医疗器械专注于一次性电子内窥镜及微创专科机器人领域，是集研发、生产、销售及服务于一体的医疗科技企业，产品涉及呼吸科、泌尿科、五官科、...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2462295183?lang=zh_CN&edition=full","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20191108171707545_s.jpg","is_english":false,"pubTime":"2024-08-27 12:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2462295183","market":"sh","top_or_hot":-1,"title":"领航医药生物科技(00399.HK)拟设合营 拓中国一次性体检用消化内窥镜市场","media":"阿斯达克财经","content":"<div>\n<p>领航医药生物科技(00399.HK) 公布，就可能成立合营企业与策略伙伴湖南省华芯医疗器械订立谅解备忘录，双方拟合作开拓及发展中国一次性体检用消化内窥镜市场。双方亦同意讨论可能合营企业于中国的可行性及发展，并致力于10月31日或之前订立具法律约束力的合营企业协议。华芯医疗器械专注于一次性电子内窥镜及微创专科机器人领域，是集研发、生产、销售及服务于一体的医疗科技企业，产品涉及呼吸科、泌尿科、五官科、...</p>\n\n<a href=\"http://www.aastocks.com/tc/stocks/analysis/china-hot-topic-content.aspx?id=NOW.1375633&catg=4&source=AAFN\">网页链接</a>\n\n</div>\n","source":"aastocks_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>领航医药生物科技(00399.HK)拟设合营 拓中国一次性体检用消化内窥镜市场</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n领航医药生物科技(00399.HK)拟设合营 拓中国一次性体检用消化内窥镜市场\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-27 12:07 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.aastocks.com/tc/stocks/analysis/china-hot-topic-content.aspx?id=NOW.1375633&catg=4&source=AAFN><strong>阿斯达克财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>领航医药生物科技(00399.HK) 公布，就可能成立合营企业与策略伙伴湖南省华芯医疗器械订立谅解备忘录，双方拟合作开拓及发展中国一次性体检用消化内窥镜市场。双方亦同意讨论可能合营企业于中国的可行性及发展，并致力于10月31日或之前订立具法律约束力的合营企业协议。华芯医疗器械专注于一次性电子内窥镜及微创专科机器人领域，是集研发、生产、销售及服务于一体的医疗科技企业，产品涉及呼吸科、泌尿科、五官科、...</p>\n\n<a href=\"http://www.aastocks.com/tc/stocks/analysis/china-hot-topic-content.aspx?id=NOW.1375633&catg=4&source=AAFN\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1124","symbol_name":"贸易公司与经销商","start_time":0,"source_url":"http://www.aastocks.com/tc/stocks/analysis/china-hot-topic-content.aspx?id=NOW.1375633&catg=4&source=AAFN","article_id":"2462295183","we_media_id":null,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20191108171707545_s.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2462295183","pubTimestamp":1724731620,"sourceInfo":{"source_id":"aastocks_highlight","name":"阿思達克財經"},"weMediaInfo":null,"summary":"领航医药生物科技公布，就可能成立合营企业与策略伙伴湖南省华芯医疗器械订立谅解备忘录，双方拟合作开拓及发展中国一次性体检用消化内窥镜市场。领航医药生物科技相信，与华芯医疗器械的业务合作及可能成立合营企业符合集团把握医疗科技发展的策略，从而为集团创造机会，扩阔其在医疗领域的业务范畴，并提升收入增长潜力。","collect":0,"end_time":0,"defaultTopTitle":"aastocks.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1124":"贸易公司与经销商","00399":"领航医药生物科技"},"translate_title":"Linghang Pharmaceutical Biotechnology (00399. HK) plans to establish a joint venture to expand the digestive endoscope market for disposable physical examination in China","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00399":1},"content_text":"领航医药生物科技(00399.HK) 公布，就可能成立合营企业与策略伙伴湖南省华芯医疗器械订立谅解备忘录，双方拟合作开拓及发展中国一次性体检用消化内窥镜市场。双方亦同意讨论可能合营企业于中国的可行性及发展，并致力于10月31日或之前订立具法律约束力的合营企业协议。华芯医疗器械专注于一次性电子内窥镜及微创专科机器人领域，是集研发、生产、销售及服务于一体的医疗科技企业，产品涉及呼吸科、泌尿科、五官科、消化科、骨科、动物、工业应用等领域。领航医药生物科技相信，与华芯医疗器械的业务合作及可能成立合营企业符合集团把握医疗科技发展的策略，从而为集团创造机会，扩阔其在医疗领域的业务范畴，并提升收入增长潜力。为达致上述目的，集团将继续寻找集资机会，并拟将约一半集资款项拨作新业务发展之用。(jl/da)(港股报价延迟最少十五分钟。)AASTOCKS新闻","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2462295183"}

领航医药生物科技(00399.HK)拟设合营 拓中国一次性体检用消化内窥镜市场

精彩评论

领航医药生物科技(00399.HK)拟设合营拓中国一次性体检用消化内窥镜市场